Weekly shot aims to shrink waistlines in major obesity trial
NCT ID NCT06712836
Summary
This study is testing whether a new weekly injection called MET097 helps people with obesity or overweight lose weight compared to a placebo shot. About 225 adults will receive either the drug or a placebo for 28 weeks to see which group loses more weight and has fewer side effects. The goal is to see if this weekly treatment can safely help control weight over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site MET097 24-201-001
Anaheim, California, 92801, United States
-
Research Site MET097 24-201-002
Hollywood, Florida, 33024, United States
Conditions
Explore the condition pages connected to this study.